QuidelOrtho Corporation (QDEL)
25.17
-0.10 (-0.40%)
At close: Apr 17, 2025, 3:59 PM
25.20
0.12%
After-hours: Apr 17, 2025, 07:42 PM EDT
QuidelOrtho Revenue Breakdown
| Period Ending | Sep 29, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Oct 1, 2023 | Jul 2, 2023 | Jan 1, 2023 | Oct 2, 2022 | Jul 3, 2022 |
|---|---|---|---|---|---|---|---|---|---|
| Other Revenue | 126.5M | 124.2M | 116.2M | 235.7M | 123.2M | 124.4M | 114.6M | 111.7M | 59.5M |
| Other Revenue Growth | +1.85% | +6.88% | -50.70% | +91.31% | -0.96% | +8.55% | +2.60% | +87.73% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2023 |
|---|---|
| China Revenue | 310.1M |
| China Revenue Growth | n/a |
| Emea Segment Revenue | 327.3M |
| Emea Segment Revenue Growth | n/a |
| North America Segment Revenue | 1.88B |
| North America Segment Revenue Growth | n/a |
| Other Revenue | 483.3M |
| Other Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Dec 29, 2024 | Sep 29, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Oct 1, 2023 | Jul 2, 2023 | Apr 2, 2023 | Jan 1, 2023 | Oct 2, 2022 | Jul 3, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 187.5M | 186.4M | 188.2M | 204.7M | 187.6M | 194.1M | 179.1M | 202.4M | 213.6M | 204.2M | 118.4M | 89.9M | 78.7M | 67.89M | 59.24M | 53.74M | 58.4M | 53.82M | 43.25M | 45.07M | 42.3M | 38.74M | 39.8M | 43.02M | 38.68M | 37.12M | 39.05M | 39.09M | 35.08M | 19.48M | 19.14M | 20.73M | 17.98M | 18.41M | 18.89M | 19.61M | 19.47M | 18M | 17.88M | 21.25M |
| Selling, General, and Administrative Revenue Growth | +0.59% | -0.96% | -8.06% | +9.12% | -3.35% | +8.38% | -11.51% | -5.24% | +4.60% | +72.47% | +31.71% | +14.22% | +15.93% | +14.61% | +10.23% | -7.99% | +8.51% | +24.46% | -4.05% | +6.54% | +9.18% | -2.66% | -7.48% | +11.22% | +4.19% | -4.92% | -0.12% | +11.42% | +80.11% | +1.75% | -7.64% | +15.31% | -2.38% | -2.51% | -3.66% | +0.69% | +8.17% | +0.67% | -15.85% | n/a |
| Research and Development Revenue | 47.3M | 55.9M | 56.3M | 59.2M | 59.3M | 62.4M | 62.8M | 62.3M | 64.3M | 65.6M | 34.2M | 26.37M | 26.11M | 23.68M | 22.61M | 23.3M | 25.5M | 21.45M | 20.97M | 16.38M | 14.92M | 11.98M | 11.72M | 13.93M | 12.64M | 13.1M | 13.28M | 12.62M | 10.67M | 7.47M | 7.63M | 7.88M | 7.51M | 8.8M | 9.66M | 12.71M | 9.94M | 8.42M | 9.11M | 8.05M |
| Research and Development Revenue Growth | -15.38% | -0.71% | -4.90% | -0.17% | -4.97% | -0.64% | +0.80% | -3.11% | -1.98% | +91.81% | +29.70% | +1.00% | +10.27% | +4.70% | -2.96% | -8.59% | +18.87% | +2.28% | +28.03% | +9.75% | +24.62% | +2.16% | -15.84% | +10.20% | -3.53% | -1.36% | +5.25% | +18.24% | +42.93% | -2.08% | -3.15% | +4.89% | -14.69% | -8.85% | -24.01% | +27.85% | +18.05% | -7.53% | +13.09% | n/a |